Learn About The SAFE-D Study
In this interview, Dr. Victoria Goss, PhD, Associate Professor of Early Diagnosis and Translational Research, and Head of Early Diagnosis and Translational Group at the Southampton Clinical Trials Unit, discusses the SAFE-D study, the world’s largest study for early detection of pancreatic cancer in patients newly diagnosed with type 2 diabetes. Learn why the study […]
Interview With An Expert – Dr. Talia Golan: Everything You Need To Know About The Evolving Landscape of Pancreatic Cancer Detection
The realm of cancer detection has seen notable advancements, with tests designed to detect a myriad of cancers and those precision-engineered for specific ones. A question then emerges: for a condition as critical as pancreatic cancer, should one lean towards a multi-cancer detection test like Grail’s Galleri or a targeted test like Avantect? Here’s why we advocate the latter.
Targeted Testing For Pancreatic Cancer: Avantect Vs. Multi-Cancer Tests
The realm of cancer detection has seen notable advancements, with tests designed to detect a myriad of cancers and those precision-engineered for specific ones. A question then emerges: for a condition as critical as pancreatic cancer, should one lean towards a multi-cancer detection test like Grail’s Galleri or a targeted test like Avantect? Here’s why we advocate the latter.